Astria Therapeutics, Inc. Retained Earnings
Astria Therapeutics, Inc. had Retained Earnings of -$773.20 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-11-12
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$773.20M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$741.55M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$708.50M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$674.79M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-09-30 | -$773.20M 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$741.55M 10-Q · filed 2025-08-12 |
| 2025-03-31 | -$708.50M 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$674.79M 10-Q · filed 2025-11-12 |
| 2024-09-30 | -$649.17M 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$624.63M 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$600.46M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$580.53M 10-K · filed 2025-03-11 |
| 2023-09-30 | -$549.12M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$531.40M 10-Q · filed 2023-08-07 |
| 2023-03-31 | -$518.83M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$507.64M 10-K · filed 2024-03-04 |
| 2022-09-30 | -$494.38M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$482.38M 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$471.13M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$455.81M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$446.32M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$438.45M 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$430.98M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$260.90M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$251.92M 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$241.06M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$231.55M 10-Q · filed 2020-05-12 |
| 2019-12-31 | -$223.60M 10-K/A · filed 2021-04-19 |
| 2019-09-30 | -$216.99M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$210.47M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$203.34M 10-Q · filed 2019-05-14 |
| 2018-12-31 | -$197.30M 10-K · filed 2020-03-10 |
| 2018-09-30 | -$191.24M 10-Q · filed 2018-11-13 |
| 2018-06-30 | -$185.56M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$179.09M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$171.43M 10-K · filed 2019-03-14 |
| 2017-09-30 | -$165.94M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$158.92M 10-Q · filed 2017-08-10 |
| 2017-03-31 | -$151.95M 10-Q · filed 2017-05-11 |
| 2016-12-31 | -$144.07M 10-K · filed 2018-03-15 |
| 2016-09-30 | -$135.29M 10-Q · filed 2016-11-10 |
| 2016-06-30 | -$126.87M 10-Q · filed 2016-08-11 |
| 2016-03-31 | -$117.43M 10-Q · filed 2016-05-12 |
| 2015-12-31 | -$108.01M 10-K · filed 2017-03-16 |
| 2015-09-30 | -$98.40M 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$89.92M 10-Q · filed 2015-08-13 |
| 2014-12-31 | -$75.38M 10-K · filed 2016-03-15 |